143 related articles for article (PubMed ID: 34728321)
1. The evaluation of the effect of different superdisintegrants on the drug release from FDM 3D printed tablets through different applied strategies: In vitro-in silico assessment.
Đuranović M; Madžarević M; Ivković B; Ibrić S; Cvijić S
Int J Pharm; 2021 Dec; 610():121194. PubMed ID: 34728321
[TBL] [Abstract][Full Text] [Related]
2. Formulation of 3D Printed Tablet for Rapid Drug Release by Fused Deposition Modeling: Screening Polymers for Drug Release, Drug-Polymer Miscibility and Printability.
Solanki NG; Tahsin M; Shah AV; Serajuddin ATM
J Pharm Sci; 2018 Jan; 107(1):390-401. PubMed ID: 29066279
[TBL] [Abstract][Full Text] [Related]
3. Tailoring immediate release FDM 3D printed tablets using a quality by design (QbD) approach.
Than YM; Titapiwatanakun V
Int J Pharm; 2021 Apr; 599():120402. PubMed ID: 33640426
[TBL] [Abstract][Full Text] [Related]
4. Development of immediate release (IR) 3D-printed oral dosage forms with focus on industrial relevance.
Fanous M; Gold S; Hirsch S; Ogorka J; Imanidis G
Eur J Pharm Sci; 2020 Dec; 155():105558. PubMed ID: 32946957
[TBL] [Abstract][Full Text] [Related]
5. Role of release modifiers to modulate drug release from fused deposition modelling (FDM) 3D printed tablets.
Shi K; Salvage JP; Maniruzzaman M; Nokhodchi A
Int J Pharm; 2021 Mar; 597():120315. PubMed ID: 33540000
[TBL] [Abstract][Full Text] [Related]
6. Low temperature fused deposition modeling (FDM) 3D printing of thermolabile drugs.
Kollamaram G; Croker DM; Walker GM; Goyanes A; Basit AW; Gaisford S
Int J Pharm; 2018 Jul; 545(1-2):144-152. PubMed ID: 29705104
[TBL] [Abstract][Full Text] [Related]
7. A Lower Temperature FDM 3D Printing for the Manufacture of Patient-Specific Immediate Release Tablets.
Okwuosa TC; Stefaniak D; Arafat B; Isreb A; Wan KW; Alhnan MA
Pharm Res; 2016 Nov; 33(11):2704-12. PubMed ID: 27506424
[TBL] [Abstract][Full Text] [Related]
8. Preparation and In vitro Evaluation of FDM 3D-Printed Ellipsoid-Shaped Gastric Floating Tablets with Low Infill Percentages.
Chen D; Xu XY; Li R; Zang GA; Zhang Y; Wang MR; Xiong MF; Xu JR; Wang T; Fu H; Hu Q; Wu B; Yan GR; Fan TY
AAPS PharmSciTech; 2019 Nov; 21(1):6. PubMed ID: 31754916
[TBL] [Abstract][Full Text] [Related]
9. Simplification of fused deposition modeling 3D-printing paradigm: Feasibility of 1-step direct powder printing for immediate release dosage form production.
Fanous M; Gold S; Muller S; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2020 Mar; 578():119124. PubMed ID: 32035253
[TBL] [Abstract][Full Text] [Related]
10. [Preparation and
Chen D; Xu XY; Wang MR; Li R; Zang GA; Zhang Y; Qian HN; Yan GR; Fan TY
Beijing Da Xue Xue Bao Yi Xue Ban; 2021 Mar; 53(2):348-354. PubMed ID: 33879910
[TBL] [Abstract][Full Text] [Related]
11. Development of immediate release 3D-printed dosage forms for a poorly water-soluble drug by fused deposition modeling: Study of morphology, solid state and dissolution.
Fanous M; Bitar M; Gold S; Sobczuk A; Hirsch S; Ogorka J; Imanidis G
Int J Pharm; 2021 Apr; 599():120417. PubMed ID: 33647418
[TBL] [Abstract][Full Text] [Related]
12. Predicting drug release from diazepam FDM printed tablets using deep learning approach: Influence of process parameters and tablet surface/volume ratio.
Obeid S; Madžarević M; Krkobabić M; Ibrić S
Int J Pharm; 2021 May; 601():120507. PubMed ID: 33766640
[TBL] [Abstract][Full Text] [Related]
13. Development of modified release 3D printed tablets (printlets) with pharmaceutical excipients using additive manufacturing.
Goyanes A; Fina F; Martorana A; Sedough D; Gaisford S; Basit AW
Int J Pharm; 2017 Jul; 527(1-2):21-30. PubMed ID: 28502898
[TBL] [Abstract][Full Text] [Related]
14. Immediate Release 3D-Printed Tablets Produced Via Fused Deposition Modeling of a Thermo-Sensitive Drug.
Kempin W; Domsta V; Grathoff G; Brecht I; Semmling B; Tillmann S; Weitschies W; Seidlitz A
Pharm Res; 2018 Apr; 35(6):124. PubMed ID: 29679157
[TBL] [Abstract][Full Text] [Related]
15. Investigations of process parameters during dissolution studies of drug loaded 3D printed tablets.
Sharma V; Shaik KM; Choudhury A; Kumar P; Kala P; Sultana Y; Shukla R; Kumar D
Proc Inst Mech Eng H; 2021 May; 235(5):523-529. PubMed ID: 33570013
[TBL] [Abstract][Full Text] [Related]
16. 3D printed spherical mini-tablets: Geometry versus composition effects in controlling dissolution from personalised solid dosage forms.
Ayyoubi S; Cerda JR; Fernández-García R; Knief P; Lalatsa A; Healy AM; Serrano DR
Int J Pharm; 2021 Mar; 597():120336. PubMed ID: 33545280
[TBL] [Abstract][Full Text] [Related]
17. 3D printed extended release tablets for once daily use: An in vitro and in vivo evaluation study for a personalized solid dosage form.
Gültekin HE; Tort S; Tuğcu-Demiröz F; Acartürk F
Int J Pharm; 2021 Mar; 596():120222. PubMed ID: 33484916
[TBL] [Abstract][Full Text] [Related]
18. Development of 3D Printed Tablets by Fused Deposition Modeling Using Polyvinyl Alcohol as Polymeric Matrix for Rapid Drug Release.
Wei C; Solanki NG; Vasoya JM; Shah AV; Serajuddin ATM
J Pharm Sci; 2020 Apr; 109(4):1558-1572. PubMed ID: 32004538
[TBL] [Abstract][Full Text] [Related]
19. 3D printing of modified-release aminosalicylate (4-ASA and 5-ASA) tablets.
Goyanes A; Buanz AB; Hatton GB; Gaisford S; Basit AW
Eur J Pharm Biopharm; 2015 Jan; 89():157-62. PubMed ID: 25497178
[TBL] [Abstract][Full Text] [Related]
20. Hydrophilic excipients in digital light processing (DLP) printing of sustained release tablets: Impact on internal structure and drug dissolution rate.
Krkobabić M; Medarević D; Cvijić S; Grujić B; Ibrić S
Int J Pharm; 2019 Dec; 572():118790. PubMed ID: 31678382
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]